CAH vs MCK vs MDLN Stock Comparison

Cardinal Health, Mckesson and Medline Prices as of Nov 13, 2026 Peers: Industry group
CAH Cardinal Health Inc
$281.08 +13.4% 1M +36.4% 1Y
Market cap
$65.63B
P/E
36.1x
Revenue (TTM)
$257.75B
Div. yield
0.01%
Drug Distribution Healthcare
6 wins
MCK Mckesson Corp
$1,102.82 +12.7% 1M +30.3% 1Y
Market cap
$128.18B
P/E
27.3x
Revenue (TTM)
$418.79B
Div. yield
0.00%
Drug Distribution Healthcare
5 wins
MDLN Medline Inc.
$39.47 +9.9% 1M
Market cap
$34.23B
P/E
40.7x
Revenue (TTM)
$30.68B
Div. yield
–
Medical Supplies Healthcare
1 win

Head to Head

12 decided of 12

Cardinal Health leads on 6 of the 12 questions below (Cardinal Health 6, Mckesson 5, Medline 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCAHMCKMDLNLeader
Larger companyMarket capitalisation $65.63B $128.18B $34.23B MCK
Cheaper on earningsLower P/E, profitable companies only 36.1x 27.3x 40.7x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 22.8x 26.5x MCK
Faster revenue growthRevenue growth, trailing twelve months +10.0% +8.2% — CAH
More profitableNet margin, trailing twelve months 0.7% 1.1% 2.7% MDLN
Better return on capitalReturn on invested capital 36.5% 98.7% 4.3% MCK
Less leveragedLower net debt / EBITDA 1.0x 0.4x 3.2x MCK
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% CAH
Better 1-year returnPrice return, last 12 months +36.4% +30.3% — CAH
Better 5-year returnAnnualised price return, 5 years +40.5%/yr +37.5%/yr — CAH
Less volatileAnnualised volatility, 1 year 25.9% 31.4% 47.8% CAH
Higher overall scoreMean of the five percentile scores vs peers 60/100 58/100 53/100 CAH

Percentile Scorecard

CAHMCKMDLN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCAHMCKMDLN
Valuation 77 #7 of 27 65 #10 of 27 78 #54 of 243
Growth 68 #9 of 26 56 #12 of 26 –
Profitability 60 #11 of 26 56 #12 of 26 73 #60 of 222
Financial Health 40 #16 of 26 56 #12 of 26 43 #143 of 248
Shareholder Returns 53 #9 of 18 59 #8 of 18 17 #132 of 158
Overall 60 58 53
  • CAH ranked among 27 companies in Healthcare Payers and Distributors
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • MDLN ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCAHMCKMDLNSPY
1 month +13.4%+12.7%+9.9% -2.0%
3 months +19.5%+26.9%+10.4% -2.8%
6 months +44.0%+45.0%+9.1% +2.0%
Year to date +36.8%+34.4%-6.0% +10.6%
1 year +36.4%+30.3%— +12.2%
3 years +173.2%+143.0%— +68.1%
3 years, per year +39.8%+34.5%— +18.9%
5 years +446.4%+390.5%— +61.4%
5 years, per year +40.5%+37.5%— +10.1%
10 years +293.8%+671.0%— +248.5%
10 years, per year +14.7%+22.7%— +13.3%

Risk

MeasureCAHMCKMDLNSPY
Volatility, 1Y 25.9%31.4%47.8% 13.6%
Downside volatility, 1Y 24.8%27.2%48.2% 13.9%
Beta vs S&P 500, 1Y -0.01-0.180.74 1.00
Return / volatility, 1Y 1.410.97— 0.90
Max drawdown, 5Y -21.0%-27.2%-36.7% -25.4%
From 52-week high 0.0%0.0%-21.0% -3.2%
52-week high $281.08$1,102.82$49.99 $779.14
52-week low $182.50$725.17$31.64 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCAHMCKMDLN
P/E now vs peer median 35.9xmedian 25.2x 27.3xmedian 25.2x 41.1xmedian 26.5x
P/S now vs peer median 0.3xmedian 0.4x 0.3xmedian 0.4x 1.7xmedian 2.7x
EV/EBITDA now vs peer median 18.7xmedian 14.5x 17.4xmedian 14.5x 21.6xmedian 18.4x
P/FCF now vs peer median 13.3xmedian 16.5x 17.9xmedian 16.5x 27.4xmedian 25.4x
P/B now vs peer median -21.5xmedian 2.7x -32.2xmedian 2.7x 2.7xmedian 2.5x
PEG now vs peer median 0.40median 1.72 1.72median 1.72 —median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCAHMCKMDLN
Revenue $257.75B $418.79B $30.68B
Gross profit $10.05B $15.37B $7.90B
Operating income $2.70B $6.69B $1.74B
Net income $1.82B $5.43B $889.00M
Free cash flow $4.90B $7.11B $1.90B
EPS (diluted) $7.80 $40.27 $0.64
Cash & equivalents $5.26B $6.53B $2.32B
Total debt $8.82B $9.21B $12.58B
Shares (diluted) 233.00M 116.70M 1.32B
Enterprise value $48.80B $109.56B $23.77B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCAHMCKMDLN
P/E 35.9x 27.3x 41.1x
P/FCF 13.3x 17.9x 27.4x
P/Operating cash flow 11.6x 17.0x 21.8x
P/S 0.3x 0.3x 1.7x
P/B -21.5x -32.2x 2.7x
P/Tangible book -21.5x -16.1x 8.6x
EV/EBITDA 18.7x 17.4x 21.6x
EV/EBIT 25.4x 19.4x 35.0x
EV/Revenue 0.3x 0.3x 2.0x
EV/FCF 14.0x 18.3x 32.1x
EV/Operating cash flow 12.2x 17.3x 25.6x
PEG (3Y EPS CAGR) 0.40 1.72 –

Growth

14 metrics
MetricCAHMCKMDLN
Revenue growth (1Y) 10.0% 8.2% –
Revenue CAGR (3Y) 7.1% 12.9% –
Gross profit growth (1Y) 17.1% 11.8% –
Gross profit CAGR (3Y) 12.6% 7.6% –
Operating income growth (1Y) 13.6% 27.3% –
Operating income CAGR (3Y) 63.6% 16.1% –
Net income growth (1Y) 13.6% 28.5% –
Net income CAGR (3Y) 86.5% 14.2% –
EPS growth (1Y) 16.9% 24.2% –
EPS CAGR (3Y) 90.8% 15.9% –
Operating cash flow growth (1Y) 11.6% 9.3% –
Operating cash flow CAGR (3Y) 18.7% 15.2% –
Free cash flow growth (1Y) 10.1% 11.8% –
Free cash flow CAGR (3Y) 19.9% 16.3% –

Profitability

14 metrics
MetricCAHMCKMDLN
Gross margin 3.9% 3.7% 25.7%
EBITDA margin 1.4% 1.8% 9.2%
Operating margin 1.0% 1.6% 5.7%
Pretax margin 0.9% 1.6% 3.6%
Net margin 0.7% 1.1% 2.7%
FCF margin 1.9% 1.7% 6.2%
Operating cash flow margin 2.2% 1.8% 7.8%
Return on equity – – 4.6%
Return on assets 3.1% 6.0% 2.2%
Return on invested capital 36.5% 98.7% 4.3%
Return on capital employed 22.3% 42.0% 4.8%
Asset turnover 4.4x 4.6x 0.8x
Cash conversion (OCF / net income) 3.1x 1.4x 2.7x
Stock comp / revenue 0.1% – 0.4%

Financial Health

11 metrics
MetricCAHMCKMDLN
Debt / assets 14.8% 10.0% 31.3%
Debt / equity -2.9x -2.3x 0.6x
Net debt / EBITDA 1.0x 0.4x 3.2x
Debt / FCF 1.8x 1.3x 6.6x
Liabilities / assets 105.1% 104.3% 51.7%
Equity / assets -5.1% -4.3% 48.3%
Interest coverage 7.9x 21.9x –
Current ratio 0.9x 0.9x 4.0x
Quick ratio 0.4x 0.5x 2.4x
Cash ratio 0.1x 0.1x 1.2x
Altman Z-score 5.05 5.83 2.70

Shareholder Returns

7 metrics
MetricCAHMCKMDLN
Dividend yield 0.7% 0.3% –
Net buyback yield 2.3% 5.2% -13.6%
Shareholder yield 3.0% 5.6% -13.6%
Payout ratio (earnings) 26.8% 7.4% –
Payout ratio (FCF) 10.0% 5.6% –
Dividend growth (1Y) -1.4% 10.5% –
Dividend CAGR (3Y) -1.7% 9.8% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCAHMCKMDLN
Forward P/E 22.8xFY2027 22.8xFY2026 26.5xFY2026
EPS, next fiscal year $12.31FY2027 $48.34FY2026 $1.49FY2026
EPS growth, next FY +9.3%FY2027 +23.6%FY2026 +4.2%FY2026
EPS growth, the year after +12.8% +11.9% +9.4%
Revenue, next fiscal year $273.40BFY2027 $447.65BFY2026 $32.69BFY2026
Revenue growth, next FY +7.5%FY2027 +11.0%FY2026 +15.0%FY2026
Revenue growth, the year after -3.5% +1.5% +8.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCAHMCKMDLN
Held by institutions 87.4% 89.1% 57.1%
Institutions holding 1,494 2,014 409
Change in shares held, QoQ +2.8% -0.7% +17.9%
Institutions buying 711 883 322
Institutions selling 559 793 69
Buyers to sellers 1.27 1.11 4.67

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CAHMCKMDLN
CAH 1.00 0.73 0.28
MCK 0.73 1.00 0.24
MDLN 0.28 0.24 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CAH, MCK and MDLN?

Mckesson (MCK) is the largest by market capitalisation: Cardinal Health (CAH) $65.63B, Mckesson (MCK) $128.18B, Medline (MDLN) $34.23B.

Which stock is cheaper, CAH, MCK and MDLN?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (Cardinal Health (CAH) 36.1x, Mckesson (MCK) 27.3x, Medline (MDLN) 40.7x). On next year's consensus earnings, Mckesson (MCK) is cheapest (Cardinal Health (CAH) 22.8x, Mckesson (MCK) 22.8x, Medline (MDLN) 26.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cardinal Health (CAH) grew revenue fastest over the trailing twelve months: Cardinal Health (CAH) +10.0%, Mckesson (MCK) +8.2%.

Which company is more profitable?

Medline (MDLN) has the highest net margin (Cardinal Health (CAH) 0.7%, Mckesson (MCK) 1.1%, Medline (MDLN) 2.7%). On return on invested capital, Mckesson (MCK) leads (Cardinal Health (CAH) 36.5%, Mckesson (MCK) 98.7%, Medline (MDLN) 4.3%).

Which stock has performed better?

Over the past year Cardinal Health (CAH) returned the most: Cardinal Health (CAH) +36.4%, Mckesson (MCK) +30.3%. Over five years, Cardinal Health (CAH) compounded fastest (Cardinal Health (CAH) +40.5%/yr, Mckesson (MCK) +37.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cardinal Health (CAH) has the highest dividend yield: Cardinal Health (CAH) 0.01%, Mckesson (MCK) 0.00%, Medline (MDLN) 0.00%. Medline (MDLN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cardinal Health (CAH) has been the steadiest (Cardinal Health (CAH) 25.9%, Mckesson (MCK) 31.4%, Medline (MDLN) 47.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CAH, MCK and MDLN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cardinal Health (CAH) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.